Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
Background: In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, received a conditional programmatic recommendation from WHO. Several model-based economic evaluations predicted that Xpert would be cost-effective across sub-Saharan Africa. We investigated the cost-effectiveness of Xpert in...
Saved in:
Main Authors: | Prof Anna Vassall, PhD (Author), Mariana Siapka, MSc (Author), Nicola Foster, MSc (Author), Lucy Cunnama, MSc (Author), Lebogang Ramma, MSc (Author), Prof Katherine Fielding, PhD (Author), Kerrigan McCarthy, MSc (Author), Prof Gavin Churchyard, PhD (Author), Prof Alison Grant, PhD (Author), Edina Sinanovic, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
by: Dr. Gavin J Churchyard, PhD, et al.
Published: (2015) -
Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study
by: Prof Heather J Zar, PhD, et al.
Published: (2013) -
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation
by: Anil Pooran, PhD, et al.
Published: (2019) -
Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
by: Ivor Langley, MSc, et al.
Published: (2014) -
Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Keertan Dheda, et al.
Published: (2014)